AIRLINK 63.78 Increased By ▲ 1.58 (2.54%)
BOP 6.14 Decreased By ▼ -0.09 (-1.44%)
CNERGY 4.87 Decreased By ▼ -0.12 (-2.4%)
DFML 14.94 Increased By ▲ 0.04 (0.27%)
DGKC 66.99 Decreased By ▼ -2.00 (-2.9%)
FCCL 17.39 Decreased By ▼ -0.34 (-1.92%)
FFBL 24.93 Increased By ▲ 0.33 (1.34%)
FFL 9.18 Decreased By ▼ -0.03 (-0.33%)
GGL 10.23 Increased By ▲ 0.33 (3.33%)
HBL 108.24 Decreased By ▼ -0.26 (-0.24%)
HUBC 116.75 Increased By ▲ 0.25 (0.21%)
HUMNL 6.63 Decreased By ▼ -0.07 (-1.04%)
KEL 4.41 Decreased By ▼ -0.05 (-1.12%)
KOSM 4.65 Decreased By ▼ -0.07 (-1.48%)
MLCF 35.87 Decreased By ▼ -1.03 (-2.79%)
OGDC 123.07 Decreased By ▼ -0.23 (-0.19%)
PAEL 22.94 Increased By ▲ 0.50 (2.23%)
PIAA 23.89 Increased By ▲ 1.67 (7.52%)
PIBTL 5.77 Increased By ▲ 0.02 (0.35%)
PPL 111.09 Increased By ▲ 0.19 (0.17%)
PRL 27.60 Increased By ▲ 0.03 (0.11%)
PTC 15.25 Increased By ▲ 1.06 (7.47%)
SEARL 53.02 Decreased By ▼ -0.23 (-0.43%)
SNGP 63.34 Decreased By ▼ -0.41 (-0.64%)
SSGC 10.83 Decreased By ▼ -0.17 (-1.55%)
TELE 9.23 Increased By ▲ 0.28 (3.13%)
TPLP 10.97 Increased By ▲ 0.24 (2.24%)
TRG 71.43 Increased By ▲ 1.13 (1.61%)
UNITY 25.00 Increased By ▲ 0.80 (3.31%)
WTL 1.38 Increased By ▲ 0.02 (1.47%)
BR100 6,751 Increased By 52.9 (0.79%)
BR30 22,646 Increased By 28.2 (0.12%)
KSE100 65,503 Increased By 612.1 (0.94%)
KSE30 21,721 Increased By 185.1 (0.86%)

THE HAGUE: Studies of pregnant women found the two most widely used Covid vaccines pose no risk to mothers or babies, the EU's drug regulator said on Tuesday.

Research involving some 65,000 women showed "growing evidence" that the Pfizer and Moderna jabs did not cause pregnancy complications, the European Medicines Agency (EMA) said.

The shots also provided increased protection against hospitalisation and death, particularly in late pregnancy, said the watchdog.

"The review did not find any sign of an increased risk of pregnancy complications, miscarriages, preterm births or adverse effects in the unborn babies following mRNA Covid-19 vaccination," the EMA said in a statement.

Pfizer and Moderna both use new Messenger RNA tecnology.

Covax delivers one billionth Covid vaccine dose

The Amsterdam-based regulator said it had carried out a "detailed review of several studies" involving around 65,000 pregnancies at different stages.

"The review of real world evidence suggests that the benefits of receiving mRNA Covid-19 vaccines during pregnancy outweighs any possible risks for expectant mothers and unborn babies," it said.

Pregnancy itself had been associated with a higher risk of severe Covid in the second and third trimesters, so expectant mothers should get vaccinated, it said.

The EMA said it would now review data for the other vaccines it has authorised "as they become available".

Comments

Comments are closed.